The Estée Lauder Companies announced Wednesday the acquisition of a minority stake in luxury skincare brand 111Skin, as the US beauty giant sharpens its focus on science-based skincare. Financial terms of the deal were not disclosed.
Founded in 2012 by Dr. Yannis Alexandrides, a plastic and reconstructive surgeon, 111Skin was initially developed to accelerate patient recovery time after procedures. The London-based brand's signature ingredient is NAC Y2, an innovative complex designed to support skin repair and maintain a healthy complexion. Since its inception, the brand has expanded to over 30 products, including the Black Diamond and Reparative collections, with prices ranging from $50 to $1,000 (€43 to €855).
This investment aligns with Estée Lauder's pivot toward "science-driven innovation," the New York-based group said, as consumers increasingly turn to "high-performance, preventative skincare."
"Skincare is entering a new phase, shaped by the convergence of procedures, longevity, and beauty, as consumers increasingly seek products that deliver visible, treatment-inspired results," said Stéphane de La Faverie, President and CEO of The Estée Lauder Companies.
"111SKIN embodies this evolution, translating Dr. Alexandrides' over 35 years of experience in surgery and aesthetic treatments into high-performance luxury skincare that is treatment-inspired and grounded in clinical insights, next-generation actives, powerful formulations, and proven efficacy. This investment, built on a consumer-centric approach and transformative innovation, reflects our Beauty Reimagined vision and underscores the significant opportunity we see to support the brand's continued growth, expanding its global reach while preserving the distinctive approach that makes it so relevant to today's consumers."
Despite the investment, Dr. Alexandrides will continue to lead 111SKIN alongside its current management team.
111Skin is currently distributed through several premium retail channels, including Harrods, Bluemercury, Nordstrom, Mandarin Oriental, and Aman, in addition to its direct-to-consumer business, which accounts for approximately 20% of sales. By region, North America represented about 40% of sales in 2025, with the brand established in China, the UK, Europe, and Asia-Pacific.
Source: Read the original report | Published: May 04, 2026